Prostaglandins and skin tumor promotion: inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D002262:Carboxy-Lyases / Q000096:biosynthesis*; D016861:Cyclooxygenase Inhibitors; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D051379:Mice; D009955:Ornithine Decarboxylase / Q000096:biosynthesis*; D010704:Phorbols / Q000037:antagonists & inhibitors*; D011458:Prostaglandins E / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology; D012867:Skin / Q000201:enzymology; D013755:Tetradecanoylphorbol Acetate / Q000037:antagonists & inhibitors*
D016861:Cyclooxygenase Inhibitors; D010704:Phorbols; D011458:Prostaglandins E; D011460:Prostaglandins F; D005439:Flufenamic Acid; D002262:Carboxy-Lyases; D009955:Ornithine Decarboxylase; D013755:Tetradecanoylphorbol Acetate; D001241:Aspirin; D007213:Indomethacin